Abstract
Background
Since the global outbreak of coronavirus disease 2019 (COVID-19), there have been several reports of mucormycosis as a secondary complication. However, the disseminated type of mucormycosis is extremely rare.
Case
A 58-year-old male patient with COVID-19 started receiving venovenous extracorporeal membrane oxygenation because of severe respiratory failure. During hospitalization, intra-abdominal hemorrhage occurred and an emergency laparotomy was performed. Subsequently, the patient suffered septic shock, and part of the small intestines and the abdominal wall became necrotic. Finally, the patient died. At autopsy, he was diagnosed with disseminated mucormycosis.
Conclusion
Disseminated mucormycosis should be considered in patients with COVID-19 with refractory sepsis unresponsive to broad-spectrum antimicrobial therapy.
【저자키워드】 invasive mucormycosis, COVID-19 associated mucormycosis, steroid, Invasive fungal infection, 【초록키워드】 COVID-19, coronavirus disease, Hospitalization, severe respiratory failure, Sepsis, Autopsy, extracorporeal membrane oxygenation, outbreak, Mucormycosis, male, Septic shock, Antimicrobial therapy, hemorrhage, abdominal wall, disseminated mucormycosis, necrotic, small intestine, patient with COVID-19, occurred, died, the patient, diagnosed, receiving, was performed, suffered, patients with COVID-19, 【제목키워드】 severe COVID-19, Case report, Patient, membrane, disseminated mucormycosis,